Keytruda SC
German Court Blocks Merck’s Subcutaneous Keytruda Over Patent Dispute with Halozyme
Merck; Keytruda SC; Halozyme; Germany; patent infringement; preliminary injunction; Munich Regional Court; subcutaneous formulation; cancer drug; MDASE patents